Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOral Cavity Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
Interventions
RADIATION

Compartmentalized Postoperative Radiotherapy

Pathology- and imaging-guided compartmentalized postoperative radiotherapy (PORT), with or without concurrent systemic treatment. Based on a predefined algorithm, PORT or specific anatomical volumes may be omitted. Dose prescription and volumes are risk-adapted.

All Listed Sponsors
collaborator

Clinical Trials Unit, Bern, Switzerland

UNKNOWN

collaborator

Fond'action contre le cancer

UNKNOWN

collaborator

University Hospital, Zürich

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

Kantonsspital Aarau

OTHER

collaborator

Oncology Institute of Southern Switzerland

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

Olgun Elicin

OTHER